I-Ethyl Nipecotate CAS 5006-62-2 Assay ≥99.0% (GC) Ikhwalithi Ephezulu
Nikeza Ngokuhlanzeka Okuphezulu kanye Nekhwalithi Ezinzile
Igama Lekhemikhali: Ethyl Nipecotate
I-CAS: 5006-62-2
Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo
Igama Lekhemikhali | Ethyl Nipecotate |
Omqondofana | I-Ethyl 3-Piperidinecarboxylate;I-Ethyl piperidine-3-carboxylate;3-Piperidinecarboxylic Acid Ethyl Ester |
Inombolo ye-CAS | 5006-62-2 |
Inombolo yeCAT | I-RF-PI271 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C8H15NO2 |
Isisindo samangqamuzana | 157.21 |
I-Melting Point | 165.0 ~ 167.0℃ |
Iphuzu elibilayo | 102-104℃ /7 mmHg (lit.) |
Ukuminyana | 1.012 g/mL ku-25℃ (lit.) |
I-Refractive Index | n20/D 1.460 (lit.) |
Ukuncibilika kwamanzi | I-Miscible |
Isimo Sokuthumela | Kuthunyelwe Ngaphansi Kwezinga Lokushisa Le-Ambient |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Uketshezi Olungenambala Kuya Kuphuzi Okuphuzi |
Amanzi | ≤0.50% |
Ukungcola Okukodwa | ≤0.50% |
Ukungcola Okuphelele | ≤1.0% |
Izinsimbi Ezisindayo | ≤20ppm |
Isivivinyo | ≥99.0% |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | Pharmaceutical Intermediates |
Iphakheji: Ibhodlela, Umgqomo, 25kg/Umgqomo, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo nomphakeli we-Ethyl Nipecotate (CAS: 5006-62-2) enekhwalithi ephezulu, esetshenziswa kabanzi ku-organic synthesis, ukuhlanganiswa kwemithi ephakathi kwemithi kanye nokuhlanganiswa kwe-Active Pharmaceutical Ingredient (API).
Isicelo se-Ethyl Nipecotate (CAS: 5006-62-2) sisetshenziswe ekuhlanganiseni kwe: α,α′-bis[3-(N,N-diethylcarbamoyl)-piperidino]-p-xylene;I-2-amino-4-thiazolyl ephuma ku-3-(iso-propyl-3-piperidinyl) phenol;
Isabela ekuhlanganisweni kwe-: Squalene synthase inhibitors;I-4-aminomethyl-7,8-dihydroxycoumarines kanye nokuphuma kwayo komqhele we-ether;I-Spiroimidazolidinone NPC1L1 inhibitors;Izimoduli zokuzwa ikhoramu;I-serotonin ekhethiwe ye-5-HT6 receptor antagonists;I-Oxazolidinone RNA-binding agents.